tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Australian Clinical Labs Announces Change in Substantial Holding Status

Story Highlights
Australian Clinical Labs Announces Change in Substantial Holding Status

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Australian Clinical Labs Ltd ( (AU:ACL) ) has shared an update.

Australian Clinical Labs Limited has announced a change in its substantial holding status as of March 3, 2025. The company, which operates within the healthcare sector, has seen a shift in the relevant interests and associations of its voting securities, indicating a potential impact on its shareholder structure and market positioning.

The most recent analyst rating on (AU:ACL) stock is a Buy with a A$3.60 price target. To see the full list of analyst forecasts on Australian Clinical Labs Ltd stock, see the AU:ACL Stock Forecast page.

More about Australian Clinical Labs Ltd

Average Trading Volume: 869,831

Technical Sentiment Signal: Sell

Current Market Cap: A$536.1M

For a thorough assessment of ACL stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1